TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19168173

Group type: EXPERIMENTAL
Intervention: Specific elements of the target event
Number of subjects: 49

Group type: COMPARATOR
Intervention: Generic elements of the target event
Number of subjects: 49
Study: 17764564

Group type: EXPERIMENTAL
Intervention: ChewFree.com program for smokeless tobacco cessation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smokers' Health Improvement Program (SHIP) for smoking cessation
Number of subjects: 0
Study: 15151720

Group type: EXPERIMENTAL
Intervention: Vitrification in flexible micropipettes by immersion in LN2 (VLN)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Programmable rate freezing (PR)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Vitrification in flexible micropipettes by immersion in super-cooled liquid nitrogen (VSC)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Control (not refrozen)
Number of subjects: 429
Study: 11163812

Group type: EXPERIMENTAL
Intervention: 150 IU rFSH (n = 146)
Number of subjects: 345

Group type: COMPARATOR
Intervention: 200 IU rFSH (n = 151)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: 300 IU rFSH (n = 24)
Number of subjects: 345

Group type: COMPARATOR
Intervention: 400 IU rFSH (n = 24)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of rFSH
Number of subjects: 345

Group type: COMPARATOR
Intervention: Subcutaneous administration of rFSH
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Intramuscular 150 IU rFSH
Number of subjects: 345
Study: 9884789

Group type: EXPERIMENTAL
Intervention: NCAA Division I, II, III athletes with ACL injury
Number of subjects: 0

Group type: COMPARATOR
Intervention: NCAA Division I, II, III athletes without ACL injury
Number of subjects: 0
Study: 8021633

Group type: EXPERIMENTAL
Intervention: High dose of alcohol (blood concentration of 96mg/dL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 2342217

Group type: EXPERIMENTAL
Intervention: Topical 0.1% tretinoin
Number of subjects: 6

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 6
Study: 211984

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30953936

Group type: EXPERIMENTAL
Intervention: Data collected within procedural registries and claims databases
Number of subjects: 0

Group type: COMPARATOR
Intervention: Trial-ascertained variables and endpoints
Number of subjects: 0
Study: 28723976

Group type: EXPERIMENTAL
Intervention: Progressively trained frequency range (300-600 Hz or 3000-6000 Hz) with gradually increasing similarity of sounds during training.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Constant stimulus similarity throughout training in one frequency range.
Number of subjects: 0
Study: 26002686

Group type: EXPERIMENTAL
Intervention: GCCM (Mediterranean diet-based cooking and nutrition curriculum)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study: 23795805

Group type: EXPERIMENTAL
Intervention: prednisolone/everolimus (P/EVL)
Number of subjects: 23

Group type: COMPARATOR
Intervention: prednisolone/cyclosporine A (P/CsA)
Number of subjects: 23
Study: 21471763

Group type: EXPERIMENTAL
Intervention: Double-pursestring stapled hemorrhoidopexy
Number of subjects: 200
Study: 19622887

Group type: EXPERIMENTAL
Intervention: BoNT‐A (Dysport)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: BoNT‐A (high-dose)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: BoNT‐A (other doses)
Number of subjects: 127
Study: 19023175

Group type: EXPERIMENTAL
Intervention: MHACL intervention program
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1071
Study: 15364332

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs
Number of subjects: 2033
Study: 11216966

Group type: EXPERIMENTAL
Intervention: Oral anticoagulant therapy
Number of subjects: 3712

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 3712
Study: 9532987

Group type: EXPERIMENTAL
Intervention: Caesarean section delivery at 38 weeks
Number of subjects: 339

Group type: COMPARATOR
Intervention: Vaginal delivery
Number of subjects: 339
Study: 7807627

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole orally for 10 days
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Procaine penicillin G intramuscularly for 10 days
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Benzathin penicillin G combined with procaine penicillin G as a single dose intramuscularly
Number of subjects: 151
Study: 2692189

Group type: EXPERIMENTAL
Intervention: Albendazole, 400 mg (single dose)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Mebendazole, 600 mg (single dose)
Number of subjects: 102
Study: 811102

Group type: EXPERIMENTAL
Intervention: Controlled-release nitroglycerin (2.6 mg tablets administered three times daily)
Number of subjects: 53
Study: 11694668

Group type: EXPERIMENTAL
Intervention: Motorized treadmill intervention (5 days per week, 8 minutes per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (traditional physical therapy at least every other week)
Number of subjects: 30
Study: 31454023

Group type: EXPERIMENTAL
Intervention: Recombinant zoster vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29503110

Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 vaccine (GSK)
Number of subjects: 30527

Group type: COMPARATOR
Intervention: Hepatitis B/A vaccine (control)
Number of subjects: 30527
Study: 27169640

Group type: EXPERIMENTAL
Intervention: Seven-month multi-component intervention including policy changes to food served, employee wellness initiatives, classroom activities promoting physical activity and healthy eating, and training and technical assistance.
Number of subjects: 23
Study: 24751432

Group type: EXPERIMENTAL
Intervention: Buprenorphine-naloxone (BUP)
Number of subjects: 1269

Group type: COMPARATOR
Intervention: Methadone (MET)
Number of subjects: 1269

Group type: EXPERIMENTAL
Intervention: Both BUP and MET
Number of subjects: 1269
Study: 26845812

Group type: EXPERIMENTAL
Intervention: Partial Kangaroo Mother Care (KMC) for 8 hours per day
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control (incubators or cots)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Partial Kangaroo Mother Care (KMC)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control (regular care)
Number of subjects: 166
Study: 20056760

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (4000 IU/d for 1 month, then 2000 IU/d)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Doxercalciferol (1 microg/d)
Number of subjects: 47
Study: 17107982

Group type: EXPERIMENTAL
Intervention: Verbruggen scoring method
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Kellgren-Lawrence (KL) scoring method
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Kallman scoring method
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Global scoring method
Number of subjects: 105
Study: 15842248

Group type: EXPERIMENTAL
Intervention: Non-setting calcium hydroxide (Ca(OH)2) cement placed in the root canal system, with 22 teeth restored following conditioning of the access cavity margins and 8 teeth having the margins cleaned with a hand excavator.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Glass-ionomer cement (GIC) restoration following drying of the canal and placement of a cotton wool pledget.
Number of subjects: 62
Study: 12140638

Group type: EXPERIMENTAL
Intervention: Medium level training (group B, n = 13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Easy level training (group A, n = 14)
Number of subjects: 27
Study: 9584247

Group type: EXPERIMENTAL
Intervention: Silicone intraocular lens (IOL) through a 3.2 mm incision
Number of subjects: 200

Group type: COMPARATOR
Intervention: Poly(methyl methacrylate) (PMMA) IOL through a 5.5 mm incision
Number of subjects: 200
Study: 8609194

Group type: EXPERIMENTAL
Intervention: Microneutralization
Number of subjects: 621

Group type: COMPARATOR
Intervention: Western blot
Number of subjects: 621
Study: 2672899

Group type: EXPERIMENTAL
Intervention: iv caffeine 10 mg/kg
Number of subjects: 32

Group type: COMPARATOR
Intervention: iv saline (Control)
Number of subjects: 32
Study: 1164878

Group type: EXPERIMENTAL
Intervention: B vitamins and anabolic steroid clostebol (Steranabol)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 66
Study: 31975209

Group type: EXPERIMENTAL
Intervention: Vancomycin application in the wound
Number of subjects: 113

Group type: COMPARATOR
Intervention: No vancomycin application
Number of subjects: 113
Study: 29186635

Group type: EXPERIMENTAL
Intervention: Cognitive Patient Education (COPE) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25638752

Group type: EXPERIMENTAL
Intervention: Long-peptides plus TLR agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive design for identifying optimal treatment strategy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0
Study: 24355659

Group type: EXPERIMENTAL
Intervention: Full-dose iterative (FDI) image reconstruction
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Half-dose iterative (HDI) image reconstruction
Number of subjects: 100

Group type: COMPARATOR
Intervention: Full-dose standard (FDS) image reconstruction
Number of subjects: 100
Study: 21945081

Group type: EXPERIMENTAL
Intervention: Low-dose bupivacaine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: High-dose bupivacaine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 19541736

Group type: EXPERIMENTAL
Intervention: Incremental-load exercise
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Constant-load exercise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inhaled albuterol (400 microg)
Number of subjects: 18
Study: 18000778

Group type: EXPERIMENTAL
Intervention: IEN+rhGH
Number of subjects: 48

Group type: COMPARATOR
Intervention: IEN
Number of subjects: 48
Study: 15462191

Group type: EXPERIMENTAL
Intervention: DMPK gene molecular analysis in DM patients
Number of subjects: 31

Group type: COMPARATOR
Intervention: DMPK gene molecular analysis in controls
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Comparison of lymphocyte and muscle tissue DNA in one DM patient
Number of subjects: 31
Study: 11730442

Group type: EXPERIMENTAL
Intervention: High-dose aptiganel (5-mg bolus followed by 0.75 mg/h for 12 hours; n = 214)
Number of subjects: 628

Group type: EXPERIMENTAL
Intervention: Low-dose aptiganel (3-mg bolus followed by 0.5 mg/h for 12 hours; n = 200)
Number of subjects: 628

Group type: COMPARATOR
Intervention: Placebo (n = 214)
Number of subjects: 628
Study: 8998158

Group type: EXPERIMENTAL
Intervention: Antifibrin scintigraphy
Number of subjects: 268

Group type: COMPARATOR
Intervention: Contrast venography
Number of subjects: 268
Study: 8081045

Group type: EXPERIMENTAL
Intervention: C + R (chemotherapy with methotrexate, chlorambucil, vincristine, and cisplatin, given every 3 weeks)
Number of subjects: 151

Group type: COMPARATOR
Intervention: R (radiotherapy only, 50 Gy in the pelvis with a boost by external irradiation of the brachytherapy, cumulative dose of 68 Gy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: C + R
Number of subjects: 151

Group type: COMPARATOR
Intervention: R
Number of subjects: 151
Study: 3119022

Group type: EXPERIMENTAL
Intervention: Liberal episiotomy (51%)
Number of subjects: 674

Group type: COMPARATOR
Intervention: Restrictive episiotomy (10%)
Number of subjects: 674
Study: 29575526

Group type: EXPERIMENTAL
Intervention: JNJ‐42165279 (oral selective FAAH inhibitor)
Number of subjects: 0
Study: 28723746

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Psychotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional rehabilitation control group
Number of subjects: 60
Study: 26033499

Group type: EXPERIMENTAL
Intervention: Locoregional therapy (LRT) combined with arsenic trioxide (As2 O3) at 10 mg/d for 4 courses (21 days per course) with a 2-week interval between courses
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Locoregional therapy (LRT) combined with arsenic trioxide (As2 O3)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (group B) receiving only transarterial chemoembolization
Number of subjects: 125
Study: 24249851

Group type: EXPERIMENTAL
Intervention: Written and verbal feedback (third-year students in endocrinology class)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Written feedback only (third-year students in endocrinology class)
Number of subjects: 3

Group type: COMPARATOR
Intervention: No feedback (second-year students in cardiology class)
Number of subjects: 3
Study: 21570485

Group type: EXPERIMENTAL
Intervention: iCBT intervention
Number of subjects: 7

Group type: COMPARATOR
Intervention: Telephone support provided by NHS Direct Health Advisors
Number of subjects: 7

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) control
Number of subjects: 7
Study: 18308112

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemohormonal therapy (complete androgen blockage, docetaxel 70 mg/m2 on day 2, estramustine 280 mg three times daily on days 1 to 5 every 21 days) before radical prostatectomy.
Number of subjects: 22
Study: 16799983

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) 10 mg once daily
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 12542507

Group type: EXPERIMENTAL
Intervention: IFNbeta‐1a 30 mcg intramuscularly once weekly for 2 years
Number of subjects: 96
Study: 11059882

Group type: EXPERIMENTAL
Intervention: Type B (spacing filaments external to the fibers)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Type C (fibers waved to give Moiré structure)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Type A (standard fiber bundle)
Number of subjects: 18
Study: 9298051

Group type: EXPERIMENTAL
Intervention: 0.5% topical ketorolac
Number of subjects: 118

Group type: COMPARATOR
Intervention: 0.03% topical flurbiprofen
Number of subjects: 118
Study: 8289094

Group type: EXPERIMENTAL
Intervention: Hypofractionated Radiotherapy (HF)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Conventionally Fractionated Radiotherapy (CFR)
Number of subjects: 108
Study: 2880218

Group type: EXPERIMENTAL
Intervention: Cyclosporin therapy
Number of subjects: 25

Group type: COMPARATOR
Intervention: DST alone
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Multiparous patients or those with over 10 third-party transfusions
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: DST pretreated transplants
Number of subjects: 25
Study: 31987113

Group type: EXPERIMENTAL
Intervention: Cavacurcumin, Eicosapentaenoic acid (Omega-3s), Astaxanthin and Gamma-linoleic acid (Omega-6) (CEAG)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 28762592

Group type: EXPERIMENTAL
Intervention: Fructans
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 20
Study: 27475455

Group type: EXPERIMENTAL
Intervention: Modified Cross-Body Stretch (MCS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Modified Sleeper Stretch (MSS)
Number of subjects: 24
Study: 24916615

Group type: EXPERIMENTAL
Intervention: Systematic Tool to Reduce Inappropriate Prescribing (STRIP)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (non-STRIP)
Number of subjects: 106
Study: 22506537

Group type: EXPERIMENTAL
Intervention: Cinnarizine 20 mg/dimenhydrinate 40 mg (fixed combination)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Betahistine 12 mg
Number of subjects: 62
Study: 20409427

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alcohol administration
Number of subjects: 30
Study: 18525263

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Herpes simplex virus type 2 shedding
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Herpes simplex virus type 2 shedders
Number of subjects: 307
Study: 15725188

Group type: COMPARATOR
Intervention: No egg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Half a cooked egg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: One cooked egg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: One raw egg
Number of subjects: 41
Study: 11673338

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF, Molgramostim) 40 microg intracoronary injection followed by 10 microg/kg subcutaneous for 2 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 9540312

Group type: EXPERIMENTAL
Intervention: Experimental version of All‐Bond 2 with no water in primer A
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Commercial version of All‐Bond 2 (Bisco, Itasca, IL, USA) with 5% water in primer A
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Former version of All‐Bond 2 with 17% water in primer A
Number of subjects: 36
Study: 8087502

Group type: EXPERIMENTAL
Intervention: Meta-analyses of randomized trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Registry of randomized trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analyses based on individual data
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Collecting and conserving relevant data on ongoing trials
Number of subjects: 0
Study: 2643534

Group type: COMPARATOR
Intervention: ET after 48 to 52 hours (day 2)
Number of subjects: 758

Group type: EXPERIMENTAL
Intervention: ET after 72 to 76 hours (day 3)
Number of subjects: 758
Study: 5078403

Group type: EXPERIMENTAL
Intervention: Chloramphenicol combined with ampicillin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 100
Study: 6101550

Group type: EXPERIMENTAL
Intervention: Behaviour Therapy Programme (BTP)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Combination of Methadone Withdrawal Programme and Behaviour Therapy Programme (MBT)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Methadone Withdrawal Programme (MWP)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 23
Study: 31750110

Group type: EXPERIMENTAL
Intervention: Harmonic scalpel (HS)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Coblation
Number of subjects: 128
Study: 29021336

Group type: EXPERIMENTAL
Intervention: RAASi (renin-angiotensin-aldosterone system inhibitors)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: RAASi (within the same class)
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: RAASi to NSAIDs
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: High to low sodium intake
Number of subjects: 395
Study: 26843962

Group type: EXPERIMENTAL
Intervention: Intensive therapy group (ITG) with target HbA1c <6.2%, BP <120/75 mm Hg, LDL <80 mg/dL
Number of subjects: 2542

Group type: COMPARATOR
Intervention: Conventional therapy group (CTG) with target HbA1c <6.9%, BP <130/80 mm Hg, LDL <120 mg/dL
Number of subjects: 2542
Study: 24704117

Group type: EXPERIMENTAL
Intervention: Bulkamid (polyacrylamide hydrogel)
Number of subjects: 345

Group type: COMPARATOR
Intervention: Contigen (collagen gel)
Number of subjects: 345
Study: 22213250

Group type: EXPERIMENTAL
Intervention: HT1001
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 19281474

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 17313271

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 19
Study: 15449696

Group type: EXPERIMENTAL
Intervention: Positive behavior recall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Negative behavior recall
Number of subjects: 0
Study: 11268708

Group type: EXPERIMENTAL
Intervention: Calcichew D3 Forte (CDF)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ad Cal D3 (ACD)
Number of subjects: 102
Study: 9741406

Group type: EXPERIMENTAL
Intervention: Neuromuscular blocking agents (NMBA) and steroids
Number of subjects: 62

Group type: COMPARATOR
Intervention: Phrenic nerve conduction studies and diaphragmatic EMG
Number of subjects: 62

Group type: COMPARATOR
Intervention: Limb motor and sensory nerve conductions
Number of subjects: 62

Group type: COMPARATOR
Intervention: Muscle biopsy findings
Number of subjects: 62
Study: 7993512

Group type: EXPERIMENTAL
Intervention: Vaginal prostaglandin E2 gel
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intracervical prostaglandin E2 gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no intervention mentioned)
Number of subjects: 20
Study: 3050336

Group type: EXPERIMENTAL
Intervention: Topical fusidic acid 2% cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral dicloxacillin 500 mg twice a day
Number of subjects: 40
Study: 30680633

Group type: EXPERIMENTAL
Intervention: Combined exercise program (aerobic and resistance exercises) for 60 min per day, 3 days per week for 6 weeks
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 19
Study: 28662232

Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg every 2 weeks) administered until progression or unacceptable toxic effects.
Number of subjects: 526
Study: 26383208

Group type: EXPERIMENTAL
Intervention: Training based on the Health Belief Model
Number of subjects: 130

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 130
Study: 22925176

Group type: EXPERIMENTAL
Intervention: Oral iron (ferrous sulphate 200 mg tablets, 60 mg elemental iron, three times a day for 4 weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200 mg in divided doses on alternate days by slow intravenous infusion)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 100
Study: 21382893

Group type: EXPERIMENTAL
Intervention: Apical lead position
Number of subjects: 799

Group type: COMPARATOR
Intervention: Non-apical lead position (basal or midventricular)
Number of subjects: 799
Study: 19932356

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 microg twice a day
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 16632843

Group type: EXPERIMENTAL
Intervention: Stimulation of the posterior cord
Number of subjects: 369

Group type: COMPARATOR
Intervention: Stimulation of the lateral cord
Number of subjects: 369

Group type: COMPARATOR
Intervention: Stimulation of the medial cord
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Stimulation of more than one cord simultaneously
Number of subjects: 369